RedHill Biopharma's Opaganib Demonstrates Significant Decrease of Kidney Fibrosis

Go back to RedHill Biopharma's Opaganib Demonstrates Significant Decrease of Kidney Fibrosis
REDHILL BIO SP ADS (NASDAQ: RDHL) Delayed: 0.63 --0 (-0%)
Previous Close $0.63    52 Week High $16.54 
Open $0.62    52 Week Low $8.10 
Day High $0.65    P/E N/A 
Day Low $0.62    EPS $0.00 
Volume 15,286